Cancer Research Campaign Adjuvant Breast Trial for patients under 50.
The objectives of the Cancer Research Campaign Adjuvant Breast Trial are to determine whether the administration of a course of adjuvant tamoxifen, or ablation of ovarian function, results in a prolongation of time to recurrence or death, for women aged under 50 years and treated for operable breast cancer. The basis and aims of the trial are discussed.